Licensing Agreement to Promote Use of Human Embryonic Neural Stem Cells

(Athens, GA, USA).

Millipore has been granted an exclusive worldwide license to market the neural progenitor cells under the brand name ENStem as a component of a research kit that will also contain optimized growth media and substrates. The kit should be of particular interest to researchers studying Alzheimer's disease, spinal cord injury, or depression.

"By partnering with Aruna Biomedical, we can offer our customers a vast array of novel stem cell products and technologies,” said Patrick Schneider, vice president of the research reagents division of Millipore. "This agreement further supports Millipore's commitment to providing tools that accelerate stem cell research worldwide.”

"The potential impact of this product on the neural research community could be astounding,” commented Steven Stice, CEO of Aruna Biomedical. "By accelerating the pace of neurological research for tens of thousands of scientists, we hope to provide patients with possible therapies and treatments for debilitating neurological diseases and spinal cord injuries sooner than imagined.”


Related Links:
Millipore Corporation
Aruna Biomedical Inc